19-54939682-C-T

Variant summary

Our verdict is Benign. The variant received -21 ACMG points: 0P and 21B. BP4_StrongBP6_Very_StrongBP7BA1

The ENST00000588756.5(NLRP7):​c.1137G>A​(p.Lys379Lys) variant causes a synonymous change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.211 in 1,612,666 control chromosomes in the GnomAD database, including 36,759 homozygotes. In-silico tool predicts a benign outcome for this variant. Variant has been reported in ClinVar as Benign (★★).

Frequency

Genomes: 𝑓 0.19 ( 2952 hom., cov: 31)
Exomes 𝑓: 0.21 ( 33807 hom. )

Consequence

NLRP7
ENST00000588756.5 synonymous

Scores

2

Clinical Significance

Benign criteria provided, multiple submitters, no conflicts B:3

Conservation

PhyloP100: -6.88

Publications

16 publications found
Variant links:
Genes affected
NLRP7 (HGNC:22947): (NLR family pyrin domain containing 7) This gene encodes a member of the NACHT, leucine rich repeat, and PYD containing (NLRP) protein family. It has an N-terminal pyrin domain, followed by a NACHT domain, a NACHT-associated domain (NAD), and a C-terminal leucine-rich repeat (LRR) region. NLRP proteins are implicated in the activation of proinflammatory caspases through multiprotein complexes called inflammasomes. This gene may act as a feedback regulator of caspase-1-dependent interleukin 1-beta secretion. Alternative splicing results in multiple transcript variants encoding different isoforms. [provided by RefSeq, Jul 2008]
NLRP7 Gene-Disease associations (from GenCC):
  • hydatidiform mole, recurrent, 1
    Inheritance: AR Classification: STRONG Submitted by: Labcorp Genetics (formerly Invitae)
  • complete hydatidiform mole
    Inheritance: AR Classification: SUPPORTIVE Submitted by: Orphanet

Genome browser will be placed here

ACMG classification

Classification was made for transcript

Our verdict: Benign. The variant received -21 ACMG points.

BP4
Computational evidence support a benign effect (BayesDel_noAF=-0.86).
BP6
Variant 19-54939682-C-T is Benign according to our data. Variant chr19-54939682-C-T is described in ClinVar as Benign. ClinVar VariationId is 330172.Status of the report is criteria_provided_multiple_submitters_no_conflicts, 2 stars.
BP7
Synonymous conserved (PhyloP=-6.88 with no splicing effect.
BA1
GnomAd4 highest subpopulation (AMR) allele frequency at 95% confidence interval = 0.266 is higher than 0.05.

Transcripts

RefSeq

Gene Transcript HGVSc HGVSp Effect Exon rank MANE Protein UniProt
NLRP7NM_001127255.2 linkc.1137G>A p.Lys379Lys synonymous_variant Exon 4 of 11 NP_001120727.1 Q8WX94-3
NLRP7NM_001405531.1 linkc.1137G>A p.Lys379Lys synonymous_variant Exon 6 of 13 NP_001392460.1
NLRP7NM_139176.4 linkc.1137G>A p.Lys379Lys synonymous_variant Exon 4 of 11 NP_631915.2 Q8WX94-2

Ensembl

Gene Transcript HGVSc HGVSp Effect Exon rank TSL MANE Protein Appris UniProt
NLRP7ENST00000592784.6 linkc.1137G>A p.Lys379Lys synonymous_variant Exon 4 of 11 1 ENSP00000468706.1 Q8WX94-3

Frequencies

GnomAD3 genomes
AF:
0.189
AC:
28674
AN:
151800
Hom.:
2948
Cov.:
31
show subpopulations
Gnomad AFR
AF:
0.116
Gnomad AMI
AF:
0.239
Gnomad AMR
AF:
0.273
Gnomad ASJ
AF:
0.201
Gnomad EAS
AF:
0.167
Gnomad SAS
AF:
0.219
Gnomad FIN
AF:
0.210
Gnomad MID
AF:
0.234
Gnomad NFE
AF:
0.208
Gnomad OTH
AF:
0.202
GnomAD2 exomes
AF:
0.212
AC:
52890
AN:
249060
AF XY:
0.211
show subpopulations
Gnomad AFR exome
AF:
0.114
Gnomad AMR exome
AF:
0.302
Gnomad ASJ exome
AF:
0.212
Gnomad EAS exome
AF:
0.146
Gnomad FIN exome
AF:
0.213
Gnomad NFE exome
AF:
0.207
Gnomad OTH exome
AF:
0.227
GnomAD4 exome
AF:
0.213
AC:
311722
AN:
1460750
Hom.:
33807
Cov.:
74
AF XY:
0.213
AC XY:
154719
AN XY:
726708
show subpopulations
African (AFR)
AF:
0.116
AC:
3881
AN:
33444
American (AMR)
AF:
0.294
AC:
13126
AN:
44676
Ashkenazi Jewish (ASJ)
AF:
0.214
AC:
5579
AN:
26130
East Asian (EAS)
AF:
0.172
AC:
6821
AN:
39698
South Asian (SAS)
AF:
0.224
AC:
19307
AN:
86206
European-Finnish (FIN)
AF:
0.213
AC:
11339
AN:
53212
Middle Eastern (MID)
AF:
0.208
AC:
1072
AN:
5164
European-Non Finnish (NFE)
AF:
0.214
AC:
238192
AN:
1111904
Other (OTH)
AF:
0.206
AC:
12405
AN:
60316
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.487
Heterozygous variant carriers
0
18945
37890
56835
75780
94725
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Exome Het
Exome Hom
Variant carriers
0
8378
16756
25134
33512
41890
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
GnomAD4 genome
AF:
0.189
AC:
28688
AN:
151916
Hom.:
2952
Cov.:
31
AF XY:
0.191
AC XY:
14213
AN XY:
74254
show subpopulations
African (AFR)
AF:
0.116
AC:
4825
AN:
41468
American (AMR)
AF:
0.273
AC:
4161
AN:
15248
Ashkenazi Jewish (ASJ)
AF:
0.201
AC:
699
AN:
3470
East Asian (EAS)
AF:
0.168
AC:
859
AN:
5120
South Asian (SAS)
AF:
0.219
AC:
1052
AN:
4798
European-Finnish (FIN)
AF:
0.210
AC:
2225
AN:
10596
Middle Eastern (MID)
AF:
0.238
AC:
70
AN:
294
European-Non Finnish (NFE)
AF:
0.208
AC:
14158
AN:
67912
Other (OTH)
AF:
0.201
AC:
422
AN:
2102
Allele Balance Distribution
Red line indicates average allele balance
Average allele balance: 0.493
Heterozygous variant carriers
0
1106
2212
3318
4424
5530
0.00
0.20
0.40
0.60
0.80
0.95
Allele balance

Age Distribution

Genome Het
Genome Hom
Variant carriers
0
312
624
936
1248
1560
<30
30-35
35-40
40-45
45-50
50-55
55-60
60-65
65-70
70-75
75-80
>80
Age
Alfa
AF:
0.127
Hom.:
426
Bravo
AF:
0.189
EpiCase
AF:
0.208
EpiControl
AF:
0.211

ClinVar

Significance: Benign
Submissions summary: Benign:3
Revision: criteria provided, multiple submitters, no conflicts
LINK: link

Submissions by phenotype

not specified Benign:1
Mar 28, 2016
Laboratory for Molecular Medicine, Mass General Brigham Personalized Medicine
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

Variant identified in a genome or exome case(s) and assessed due to predicted null impact of the variant or pathogenic assertions in the literature or databases. Disclaimer: This variant has not undergone full assessment. The following are preliminary notes: Frequency -

Hydatidiform mole, recurrent, 1 Benign:1
Mar 06, 2018
Illumina Laboratory Services, Illumina
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:clinical testing

This variant was observed in the ICSL laboratory as part of a predisposition screen in an ostensibly healthy population. It had not been previously curated by ICSL or reported in the Human Gene Mutation Database (HGMD: prior to June 1st, 2018), and was therefore a candidate for classification through an automated scoring system. Utilizing variant allele frequency, disease prevalence and penetrance estimates, and inheritance mode, an automated score was calculated to assess if this variant is too frequent to cause the disease. Based on the score and internal cut-off values, a variant classified as benign is not then subjected to further curation. The score for this variant resulted in a classification of benign for this disease. -

not provided Benign:1
-
Breakthrough Genomics, Breakthrough Genomics
Significance:Benign
Review Status:criteria provided, single submitter
Collection Method:not provided

- -

Computational scores

Source: dbNSFP v4.3

Name
Calibrated prediction
Score
Prediction
BayesDel_noAF
Benign
-0.86
CADD
Benign
0.33
DANN
Benign
0.47
PhyloP100
-6.9
Mutation Taster
=100/0
polymorphism (auto)

Splicing

Name
Calibrated prediction
Score
Prediction
SpliceAI score (max)
0.0
Details are displayed if max score is > 0.2

Find out detailed SpliceAI scores and Pangolin per-transcript scores at spliceailookup.broadinstitute.org

Publications

Other links and lift over

dbSNP: rs10418277; hg19: chr19-55451050; COSMIC: COSV60174398; COSMIC: COSV60174398; API